Amicus Therapeutics Inc (FOLD)
7.35
+0.15
(+2.08%)
USD |
NASDAQ |
Apr 25, 16:00
7.355
0.00 (0.00%)
After-Hours: 20:00
Amicus Therapeutics Max Drawdown (5Y): 74.97% for March 31, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Biomarin Pharmaceutical Inc | 53.26% |
| Insmed Inc | 63.30% |
| Vanda Pharmaceuticals Inc | 89.26% |
| Vertex Pharmaceuticals Inc | 41.60% |
| NovaBay Pharmaceuticals Inc | 99.98% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -17.77 |
| Beta (5Y) | 0.7948 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 49.15% |
| Historical Sharpe Ratio (5Y) | -0.1029 |
| Historical Sortino (5Y) | -0.1705 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 18.53% |